Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Bioelectron Med 11 , 10 (2025)
Sies, H., Berndt, C
A.DworkA
Health Status: You must feel well on the day of donation and be free of active infections
Recent data from the ATTAIN-MAINTAIN trial showed that patients transitioning to orforglipron after injectable GLP-1 therapy maintained their weight loss with minimal regain (approximately 0.9 kg after semaglutide transition), suggesting that oral maintenance strategies could minimize the lean mass depletion seen with prolonged high-dose injectable therapy
US$ 29.17
US$ 22.62
US$ 20.81
US$ 23.26
US$ 23.19
US$ 23.43
US$ 23.37
US$ 26.82
